These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 14744765)
1. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Kondo T; Oue N; Yoshida K; Mitani Y; Naka K; Nakayama H; Yasui W Cancer Res; 2004 Jan; 64(2):523-9. PubMed ID: 14744765 [TBL] [Abstract][Full Text] [Related]
2. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters. Gao J; Zhang J; Long Y; Lu X Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982 [TBL] [Abstract][Full Text] [Related]
3. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer. Fujii K; Sasahira T; Moriwaka Y; Oue N; Yasui W; Kuniyasu H Int J Mol Med; 2008 May; 21(5):599-604. PubMed ID: 18425352 [TBL] [Abstract][Full Text] [Related]
4. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas. Butler KS; Hines WC; Heaphy CM; Griffith JK Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266 [TBL] [Abstract][Full Text] [Related]
5. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas. Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Haruma K; Chayama K; Yasui W; Tahara E Int J Oncol; 2001 Sep; 19(3):507-12. PubMed ID: 11494028 [TBL] [Abstract][Full Text] [Related]
6. Telomestatin-induced telomere uncapping is modulated by POT1 through G-overhang extension in HT1080 human tumor cells. Gomez D; Wenner T; Brassart B; Douarre C; O'Donohue MF; El Khoury V; Shin-Ya K; Morjani H; Trentesaux C; Riou JF J Biol Chem; 2006 Dec; 281(50):38721-9. PubMed ID: 17050546 [TBL] [Abstract][Full Text] [Related]
7. MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence. Li T; Luo Z; Lin S; Li C; Dai S; Wang H; Huang J; Ma W; Songyang Z; Huang Y Aging (Albany NY); 2020 Jul; 12(14):14791-14807. PubMed ID: 32687062 [TBL] [Abstract][Full Text] [Related]
8. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells. Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159 [TBL] [Abstract][Full Text] [Related]
9. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Lin X; Gu J; Lu C; Spitz MR; Wu X Clin Cancer Res; 2006 Oct; 12(19):5720-5. PubMed ID: 17020976 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079 [TBL] [Abstract][Full Text] [Related]
11. Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability. Bunch JT; Bae NS; Leonardi J; Baumann P Mol Cell Biol; 2005 Jul; 25(13):5567-78. PubMed ID: 15964812 [TBL] [Abstract][Full Text] [Related]
12. G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression. He Q; Zeng P; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D Biochim Biophys Acta; 2014 Jul; 1840(7):2222-33. PubMed ID: 24631651 [TBL] [Abstract][Full Text] [Related]
13. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas. Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281 [TBL] [Abstract][Full Text] [Related]
14. Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features. Izgi A; Gunal A; Yalcin S; Gunduz U Biomed Pharmacother; 2014 Sep; 68(7):841-6. PubMed ID: 25194444 [TBL] [Abstract][Full Text] [Related]
15. Telomere shortening occurs early during gastrocarcinogenesis. Mu Y; Zhang Q; Mei L; Liu X; Yang W; Yu J Med Oncol; 2012 Jun; 29(2):893-8. PubMed ID: 21359861 [TBL] [Abstract][Full Text] [Related]
16. Human POT1 facilitates telomere elongation by telomerase. Colgin LM; Baran K; Baumann P; Cech TR; Reddel RR Curr Biol; 2003 May; 13(11):942-6. PubMed ID: 12781132 [TBL] [Abstract][Full Text] [Related]
17. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Kelleher C; Kurth I; Lingner J Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080 [TBL] [Abstract][Full Text] [Related]
19. Telomerase activation without shortening of telomeric 3'-overhang is a poor prognostic factor in human colorectal cancer. Kojima K; Hiyama E; Otani K; Ohtaki M; Fukuba I; Fukuda E; Sueda T; Hiyama K Cancer Sci; 2011 Feb; 102(2):330-5. PubMed ID: 21108695 [TBL] [Abstract][Full Text] [Related]
20. Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells. Zhou H; Mondal A; Dakic A; Alhawas L; Liu X; He Z Biomed Res Int; 2018; 2018():7184253. PubMed ID: 29546066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]